0001181431-12-039891.txt : 20120705 0001181431-12-039891.hdr.sgml : 20120704 20120705191430 ACCESSION NUMBER: 0001181431-12-039891 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120701 FILED AS OF DATE: 20120705 DATE AS OF CHANGE: 20120705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McMahon Gerald PhD CENTRAL INDEX KEY: 0001290747 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 12949252 MAIL ADDRESS: STREET 1: 300 ELLIOTT AVENUE WEST STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98119-4114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4/A 1 rrd350540.xml FORM 4/A X0306 4/A 2012-07-01 2012-07-03 0 0000908259 OXIGENE INC OXGN 0001290747 McMahon Gerald PhD C/O: OXIGENE, INC. 701 GATEWAY BLVD., SUITE 210 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (Right to Buy) 0.551 2012-07-01 4 A 0 50500 0 A 2012-07-01 2018-07-01 Common Stock 50500 50500 D Dr. McMahon elected to receive options to purchase shares of OXiGENE, Inc. common stock (the "Stock Options") pursuant to the OXiGENE, Inc. Amended and Restated Non-Employee Director Compensation Policy as partial payment for Board of Directors services to be provided during the second six months of 2012. The Stock Options were fully vested as of the grant date. This amendment to the Form 4 previously filed on July 3, 2012 is being filed to correct a typographical error in each of the Transaction Date, Date Exercisable and Expiration Date columns. Megan N. Gates, Attorney-in-fact 2012-07-05